Skip to content

Clinical trials

Phase 2/3 Drug Resistant Epilepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Phase: Phase 2/3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20122
20161
20171
20201
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Active, not recruiting2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
Lady Hardinge Medical College2
PTC Therapeutics1
Sohag University1
Tehran University of Medical Sciences1
University Hospital, Grenoble1
University of Alabama at Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy10
Seizures5
Epilepsy4
Epilepsies, Partial2
Diffuse Cerebral Sclerosis of Schilder1
Epilepsy, Absence1
Epilepsy, Generalized1
Leigh Disease1
MELAS Syndrome1
MERRF Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.